Baird Medical Net Income Over Time
| BDMD Stock | 0.77 0.03 3.75% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Baird Medical Performance and Baird Medical Correlation. Will Health Care Equipment & Supplies sector continue expanding? Could Baird diversify its offerings? Factors like these will boost the valuation of Baird Medical. Projected growth potential of Baird fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Baird Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0) | Earnings Share (0.11) | Revenue Per Share | Quarterly Revenue Growth (0.39) | Return On Assets |
Baird Medical Investment's market price often diverges from its book value, the accounting figure shown on Baird's balance sheet. Smart investors calculate Baird Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Baird Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Baird Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Baird Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Baird Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income Analysis
Compare Baird Medical Investment and related stocks such as Icecure Medical, Cytosorbents Crp, and Neuroone Medical Tec Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICCM | (4.6 M) | (4.6 M) | (4.6 M) | (4.6 M) | (4.7 M) | (3.8 M) | (3.3 M) | (2.9 M) | (3.5 M) | (4.8 M) | (4.8 M) | (10.1 M) | (17.2 M) | (14.7 M) | (15.3 M) | (13.8 M) | (13.1 M) |
| CTSO | (80 K) | (5.5 M) | (3.7 M) | (4.7 M) | (9.3 M) | (8.1 M) | (11.9 M) | (8.5 M) | (17.2 M) | (19.3 M) | (7.8 M) | (24.6 M) | (32.8 M) | (29.2 M) | (20.7 M) | (18.6 M) | (17.7 M) |
| NMTC | (6 K) | (14 K) | (14 K) | (30.6 K) | (36.2 K) | (62.9 K) | (47.8 K) | (6.8 M) | (6.8 M) | (13.6 M) | (9.9 M) | (10 M) | (11.9 M) | (12.3 M) | (3.6 M) | (3.2 M) | (3.4 M) |
| BEAT | (12.7 M) | (61.4 M) | (12.2 M) | (7.3 M) | (9.8 M) | 7.4 M | 53.4 M | (16 M) | 42.8 M | (778 K) | (1.3 M) | (4.4 M) | (12.8 M) | (14.6 M) | (19.4 M) | (22.4 M) | (21.2 M) |
| ECOR | (15.7 M) | (15.7 M) | (15.7 M) | (15.7 M) | (15.7 M) | (15.7 M) | (15.7 M) | (35.8 M) | (55.8 M) | (45.1 M) | (23.5 M) | (17.2 M) | (22.2 M) | (18.8 M) | (11.9 M) | (13.7 M) | (14.4 M) |
| RBOT | (9.3 M) | (9.3 M) | (9.3 M) | (9.3 M) | (9.3 M) | (9.3 M) | (9.3 M) | (9.3 M) | (9.3 M) | (9.3 M) | (12.9 M) | (35.2 M) | 5.2 M | (71.1 M) | (63.2 M) | (56.9 M) | (54.1 M) |
| NOTV | 700 K | (6.4 M) | 773 K | (1.1 M) | 1.1 M | (3.2 M) | 884 K | (194 K) | (790 K) | (4.7 M) | 10.9 M | (337.3 M) | (105.1 M) | (108.4 M) | (68.6 M) | (61.8 M) | (58.7 M) |
| BDSX | (26.2 M) | (26.2 M) | (26.2 M) | (26.2 M) | (26.2 M) | (26.2 M) | (26.2 M) | (26.2 M) | (26.2 M) | (30.7 M) | (31.4 M) | (43.2 M) | (65.4 M) | (52.1 M) | (42.9 M) | (38.6 M) | (40.6 M) |
| OKUR | (19.5 M) | (19.5 M) | (19.5 M) | (19.5 M) | (19.5 M) | (19.5 M) | (19.5 M) | (19.5 M) | (19.5 M) | (19.5 M) | (19.5 M) | (39.8 M) | (29.5 M) | (35.3 M) | (52.7 M) | (47.4 M) | (49.8 M) |
Baird Medical Investment and related stocks such as Icecure Medical, Cytosorbents Crp, and Neuroone Medical Tec Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Baird Medical Investment financial statement analysis. It represents the amount of money remaining after all of Baird Medical Investment operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Baird Medical Investment | BDMD |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | Baide Building, Building |
| Exchange | NASDAQ Exchange |
null 0.77
Check out Baird Medical Performance and Baird Medical Correlation. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Baird Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.